SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1452Seems to me we are now dealing with a totally predictable FDA - but not in a goonigel bates-11/6/2007
1451<i>Looks like the insiders and shorts were right through today.</i> DewDiligence_on_SI-11/6/2007
1450EV now about $90M. Looks like the insiders and shorts were right through today.IRWIN JAMES FRANKEL-11/6/2007
1449Eric Schmidt of Cowen has put out a note to the effect that the entire platform/fred hayes-11/6/2007
1448Wow—I was way too early. I’m adding more here.DewDiligence_on_SI-11/6/2007
1447"I'm having a real difficult time understanding what possible immunogendr.praveen-11/6/2007
1446I'm having a real difficult time understanding what possible immunogenicity Ian@SI-11/6/2007
1445Haven't listened to the cc yet. But I don't think that this can be addredr.praveen-11/6/2007
1444Seems to me that we're dealing with a totally unpredictable FDA, which makestom pope-11/6/2007
1443Thanks, rings true to me...fred hayes-11/6/2007
1442Although enoxaparin is not a biologic, my sense is that the FDA is stalling untiDewDiligence_on_SI-11/6/2007
1441Just bought my first-ever shares @6.76 (eom).DewDiligence_on_SI-11/6/2007
1440Sounds like the dog musta ate FDA's homework. I thought MNTA's drug was fred hayes-11/6/2007
1439Per the CC - on ANDA's an "approvable letter" is not an option thuIRWIN JAMES FRANKEL-11/6/2007
1438Apparently they do issue letters :-) I'm sure your second question will brkrw-11/6/2007
1437Press Release Source: Momenta Pharmaceuticals Momenta Pharmaceuticals AnnouncesIRWIN JAMES FRANKEL-11/6/2007
1436Couple of things are odd. I did not think the agency issued not approvable lettIRWIN JAMES FRANKEL-11/6/2007
1435This is kind of interesting. Does this indicate the rest of the application, i.erkrw-11/6/2007
1434Form 8-K for MOMENTA PHARMACEUTICALS INC 6-Nov-2007 Other Events Item 8.01. OIRWIN JAMES FRANKEL-11/6/2007
1433<b> Regado Biosciences Presents Positive Data from REG1 Anticoagulation SyDewDiligence_on_SI-11/4/2007
1432Only thing I caught was increased pace of discussions as the quarter progressed.Robohogs-11/1/2007
1431I didn't catch the whole call, but towards the end of the Q&A, I noted aBiomaven-11/1/2007
1430Anyone bother with the 3rd Q CC? The PR certainly was a yawner: >>Momenttuck-11/1/2007
1429Thanks. Benefit to this taking forever, lovenox grows, detriment, competition isrkrw-10/31/2007
14283Q07 Lovenox breakdown: US €384M +15% EU €181M +10% RoW €68M +10%DewDiligence_on_SI-10/31/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News